Clinical Trial Update: Megestrol Acetate Against Cancer-related Critical Body Weight Loss in Patients With H&N Cancer Who Receiving CCRT [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating megestrol acetate for cancer-related weight loss in head and neck cancer patients receiving concurrent chemoradiation. The cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Megestrol acetate (megestrol acetate)

Snippet

Sponsor: TTY Biopharm | Conditions: Head and Neck Cancer | Phase 2 | Status: UNKNOWN